Bio-Techne

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bio-Techne and other ETFs, options, and stocks.

About TECH

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. 

CEO
Kim Kelderman
CEOKim Kelderman
Employees
3,100
Employees3,100
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
1976
Founded1976
Employees
3,100
Employees3,100

TECH Key Statistics

Market cap
9.07B
Market cap9.07B
Price-Earnings ratio
83.22
Price-Earnings ratio83.22
Dividend yield
0.55%
Dividend yield0.55%
Average volume
2.98M
Average volume2.98M
High today
$58.25
High today$58.25
Low today
$54.87
Low today$54.87
Open price
$55.49
Open price$55.49
Volume
3.63M
Volume3.63M
52 Week high
$72.16
52 Week high$72.16
52 Week low
$43.20
52 Week low$43.20

Stock Snapshot

As of today, Bio-Techne(TECH) shares are valued at $57.94. The company's market cap stands at 9.07B, with a P/E ratio of 83.22 and a dividend yield of 0.55%.

As of 2026-06-20, Bio-Techne(TECH) stock has fluctuated between $54.87 and $58.25. The current price stands at $57.94, placing the stock +5.6% above today's low and -0.5% off the high.

The Bio-Techne(TECH)'s current trading volume is 3.63M, compared to an average daily volume of 2.98M.

During the past year, Bio-Techne(TECH) stock moved between $43.20 at its lowest and $72.16 at its peak.

During the past year, Bio-Techne(TECH) stock moved between $43.20 at its lowest and $72.16 at its peak.

TECH News

MarketWatch 2d
Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch

...

Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch
Simply Wall St 2d
Bio-Techne Stock Could Be 10.4% Undervalued After Refeyn Collaboration

Bio-Techne (TECH) stock has been in focus after the company partnered with Refeyn on a four hour workflow that links charge heterogeneity, molecular weight, and...

Bio-Techne Stock Could Be 10.4% Undervalued After Refeyn Collaboration
Simply Wall St 4d
Bio-Techne Stock After 30% Monthly Jump Are Recent Gains Justified

If you are wondering whether Bio-Techne stock still offers value at around US$56.17, the recent share performance gives you a useful starting point but not the...

Bio-Techne Stock After 30% Monthly Jump Are Recent Gains Justified

Analyst ratings

58%

of 19 ratings
Buy
57.9%
Hold
36.8%
Sell
5.3%

People also own

Based on the portfolios of people who own TECH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.